首页 > 最新文献

Acta Otorhinolaryngologica Italica最新文献

英文 中文
Extended cervical approach for retrosternal multinodular goiter. 胸骨后多结节性甲状腺肿的颈部延伸入路。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 DOI: 10.14639/0392-100X-N2746
Nir Tsur, Lirit Levi, Omry Frig, Noam Koch, Yossi Eshel, Gideon Bachar, Thomas Shpitzer, Moshe Yehuda, Yuri Pescovitz, Ory Wiesel, Dean Dudkiewicz, Aviram Mizrachi

Objective: Partial or total sternotomy is required for 10% of retrosternal goiter. This study reviewed our experience with an extended cervicotomic approach as an alternative surgical solution for retrosternal goiter.

Methods: A retrospective study was performed on patients who underwent partial or total thyroidectomy for retrosternal goiter between 2014 and 2019 at a tertiary medical centre. Data on clinical, radiologic, and pathologic factors were analysed. Peri- and postoperative outcomes were compared between extended and standard cervical approaches to predict the need for an extended cervical approach.

Results: The cohort included 265 patients, of whom 245 (92.4%) were treated by standard thyroidectomy. In 17 (6.4%), the standard approach proved insufficient, and the horizontal incision was extended to a T-shape to improve access. The remaining 3 patients required a sternotomy. Use of the extended cervical approach was significantly associated with clinical features such as male gender, diabetes, high body mass index and postoperative hypocalcaemia.

Conclusions: The extended cervicotomic approach is an alternative surgical solution for retrosternal goiter, with no increased risk of significant post-operative complications.

目的:10%的胸骨后甲状腺肿需要部分或全部胸骨切开术。本研究回顾了我们采用扩展颈椎切口作为胸骨后甲状腺肿替代手术方案的经验:一项回顾性研究针对2014年至2019年期间在一家三级医疗中心接受甲状腺部分或全部切除术治疗胸骨后甲状腺肿的患者。分析了临床、放射学和病理学因素的数据。比较了延长颈部入路和标准颈部入路的围手术期和术后结果,以预测是否需要延长颈部入路:研究对象包括265名患者,其中245人(92.4%)接受了标准甲状腺切除术。在17例(6.4%)患者中,标准入路被证明是不够的,因此水平切口被扩展为T形,以改善入路。其余3名患者需要进行胸骨切开术。采用扩展颈椎入路与男性、糖尿病、高体重指数和术后低钙血症等临床特征密切相关:扩展颈椎入路是治疗胸骨后甲状腺肿的另一种手术方案,不会增加术后出现重大并发症的风险。
{"title":"Extended cervical approach for retrosternal multinodular goiter.","authors":"Nir Tsur, Lirit Levi, Omry Frig, Noam Koch, Yossi Eshel, Gideon Bachar, Thomas Shpitzer, Moshe Yehuda, Yuri Pescovitz, Ory Wiesel, Dean Dudkiewicz, Aviram Mizrachi","doi":"10.14639/0392-100X-N2746","DOIUrl":"10.14639/0392-100X-N2746","url":null,"abstract":"<p><strong>Objective: </strong>Partial or total sternotomy is required for 10% of retrosternal goiter. This study reviewed our experience with an extended cervicotomic approach as an alternative surgical solution for retrosternal goiter.</p><p><strong>Methods: </strong>A retrospective study was performed on patients who underwent partial or total thyroidectomy for retrosternal goiter between 2014 and 2019 at a tertiary medical centre. Data on clinical, radiologic, and pathologic factors were analysed. Peri- and postoperative outcomes were compared between extended and standard cervical approaches to predict the need for an extended cervical approach.</p><p><strong>Results: </strong>The cohort included 265 patients, of whom 245 (92.4%) were treated by standard thyroidectomy. In 17 (6.4%), the standard approach proved insufficient, and the horizontal incision was extended to a T-shape to improve access. The remaining 3 patients required a sternotomy. Use of the extended cervical approach was significantly associated with clinical features such as male gender, diabetes, high body mass index and postoperative hypocalcaemia.</p><p><strong>Conclusions: </strong>The extended cervicotomic approach is an alternative surgical solution for retrosternal goiter, with no increased risk of significant post-operative complications.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"44 1","pages":"21-26"},"PeriodicalIF":2.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implantable hearing devices in clinical practice. Systematic review and consensus statements. 临床实践中的植入式听力设备。系统综述和共识声明。
IF 2.1 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 Epub Date: 2023-12-29 DOI: 10.14639/0392-100X-N2651
Luca Bruschini, Pietro Canzi, Andrea Canale, Edoardo Covelli, Andrea Laborai, Marta Monteforte, Michela Cinquini, Maurizio Barbara, Millo Achille Beltrame, Roberto Bovo, Bruno Castigliano, Cosimo De Filippis, Antonio Della Volpe, Francesco Dispenza, Pasquale Marsella, Anna Mainardi, Eva Orzan, Enrico Piccirillo, Giampietro Ricci, Nicola Quaranta, Domenico Cuda

Objective: Implantable hearing devices represent a modern and innovative solution for hearing restoration. Over the years, these high-tech devices have increasingly evolved but their use in clinical practice is not universally agreed in the scientific literature. Congresses, meetings, conferences, and consensus statements to achieve international agreement have been made. This work follows this line and aims to answer unsolved questions regarding examinations, selection criteria and surgery for implantable hearing devices.

Materials and methods: A Consensus Working Group was established by the Italian Society of Otorhinolaryngology. A method group performed a systematic review for each single question to identify the current best evidence on the topic and to guide a multidisciplinary panel in developing the statements.

Results: Twenty-nine consensus statements were approved by the Italian Society of Otorhinolaryngology. These were associated with 4 key area subtopics regarding pre-operative tests, otological, audiological and surgical indications.

Conclusions: This consensus can be considered a further step forward to establish realistic guidelines on the debated topic of implantable hearing devices.

目的:植入式听力设备是现代听力恢复的创新解决方案。多年来,这些高科技设备的发展日新月异,但在临床实践中的应用在科学文献中并未得到普遍认同。为了达成国际共识,各种大会、会议和共识声明层出不穷。这项工作遵循了这一思路,旨在回答有关植入式听力设备的检查、选择标准和手术方面尚未解决的问题:意大利耳鼻喉科学会成立了一个共识工作组。方法:由意大利耳鼻喉科学会成立共识工作组,方法小组对每一个问题进行系统审查,以确定该主题的当前最佳证据,并指导多学科小组制定声明:结果:意大利耳鼻咽喉科学会批准了 29 项共识声明。这些声明与术前检查、耳科、听力和手术适应症等 4 个关键领域的子课题相关联:该共识被认为是在就植入式听力设备这一争论不休的话题制定切实可行的指导原则方面又向前迈进了一步。
{"title":"Implantable hearing devices in clinical practice. Systematic review and consensus statements.","authors":"Luca Bruschini, Pietro Canzi, Andrea Canale, Edoardo Covelli, Andrea Laborai, Marta Monteforte, Michela Cinquini, Maurizio Barbara, Millo Achille Beltrame, Roberto Bovo, Bruno Castigliano, Cosimo De Filippis, Antonio Della Volpe, Francesco Dispenza, Pasquale Marsella, Anna Mainardi, Eva Orzan, Enrico Piccirillo, Giampietro Ricci, Nicola Quaranta, Domenico Cuda","doi":"10.14639/0392-100X-N2651","DOIUrl":"10.14639/0392-100X-N2651","url":null,"abstract":"<p><strong>Objective: </strong>Implantable hearing devices represent a modern and innovative solution for hearing restoration. Over the years, these high-tech devices have increasingly evolved but their use in clinical practice is not universally agreed in the scientific literature. Congresses, meetings, conferences, and consensus statements to achieve international agreement have been made. This work follows this line and aims to answer unsolved questions regarding examinations, selection criteria and surgery for implantable hearing devices.</p><p><strong>Materials and methods: </strong>A Consensus Working Group was established by the Italian Society of Otorhinolaryngology. A method group performed a systematic review for each single question to identify the current best evidence on the topic and to guide a multidisciplinary panel in developing the statements.</p><p><strong>Results: </strong>Twenty-nine consensus statements were approved by the Italian Society of Otorhinolaryngology. These were associated with 4 key area subtopics regarding pre-operative tests, otological, audiological and surgical indications.</p><p><strong>Conclusions: </strong>This consensus can be considered a further step forward to establish realistic guidelines on the debated topic of implantable hearing devices.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"52-67"},"PeriodicalIF":2.1,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type IV optic nerve and Onodi cell: is there a risk of injury during sphenoid sinus surgery? IV 型视神经和奥诺迪细胞:蝶窦手术中是否存在损伤风险?
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 Epub Date: 2023-12-29 DOI: 10.14639/0392-100X-N2462
Gian Luca Fadda, Anastasia Urbanelli, Alessio Petrelli, Marta Trossarello, Letizia Nitro, Alberto Maria Saibene, Eugenio De Corso, Dario Gned, Marco Panfili, Giovanni Cavallo

Objective: This study aims to determine the prevalence and types of Onodi cells through computed tomography and investigate the relationship between Onodi cell and the surrounding structures, paying particular attention to the risky proximity to the optic nerve canal.

Methods: In this study, 430 computed tomography scans of paranasal sinuses were analysed to establish the prevalence and different types of Onodi cells. Furthermore, the relationship between Onodi cell and different patterns of sphenoid sinus pneumatisation and surrounding structures were investigated. Special attention was paid to the relationship between Onodi cell and the optic nerve canal, particularly in cases when the optic nerve canal was bulging by more than 50% into the Onodi cell (Type IV).

Results: The Onodi cell was detected in 21.6% of cases, with the most common being Type I (48.5% right, 54.3% left). Type IV bulging of the optic nerve canal into the Onodi cell was observed in 47.1% of cases on the right side, 41.2% on the left side and bilateral in 11.7% of cases.

Conclusions: In our series, we observed a high prevalence of Type IV optic nerve bulging into the Onodi cell. For this reason, we suggest that clinicians should always try to identify it in a pre-operative setting with computed tomography to avoid catastrophic consequences during endoscopic sinus surgery approaching the sphenoid area.

研究目的本研究旨在通过计算机断层扫描确定奥诺迪细胞的患病率和类型,并研究奥诺迪细胞与周围结构之间的关系,尤其关注靠近视神经管的风险:本研究分析了 430 例副鼻窦计算机断层扫描,以确定奥诺迪细胞的发病率和不同类型。此外,还研究了奥诺迪细胞与蝶窦气化的不同模式及周围结构之间的关系。研究还特别关注了奥诺迪细胞与视神经管之间的关系,尤其是当视神经管向奥诺迪细胞隆起超过50%时(IV型):结果:21.6%的病例发现了奥诺迪细胞,其中最常见的是 I 型(右侧 48.5%,左侧 54.3%)。47.1%的病例右侧视神经管鼓入奥诺迪细胞,41.2%的病例左侧视神经管鼓入奥诺迪细胞,11.7%的病例双侧视神经管鼓入奥诺迪细胞:在我们的系列研究中,我们观察到Ⅳ型视神经鼓入奥诺迪细胞的发病率很高。因此,我们建议临床医生在术前通过计算机断层扫描来识别这种情况,以避免在接近蝶窦区的内窥镜鼻窦手术中出现灾难性后果。
{"title":"Type IV optic nerve and Onodi cell: is there a risk of injury during sphenoid sinus surgery?","authors":"Gian Luca Fadda, Anastasia Urbanelli, Alessio Petrelli, Marta Trossarello, Letizia Nitro, Alberto Maria Saibene, Eugenio De Corso, Dario Gned, Marco Panfili, Giovanni Cavallo","doi":"10.14639/0392-100X-N2462","DOIUrl":"10.14639/0392-100X-N2462","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to determine the prevalence and types of Onodi cells through computed tomography and investigate the relationship between Onodi cell and the surrounding structures, paying particular attention to the risky proximity to the optic nerve canal.</p><p><strong>Methods: </strong>In this study, 430 computed tomography scans of paranasal sinuses were analysed to establish the prevalence and different types of Onodi cells. Furthermore, the relationship between Onodi cell and different patterns of sphenoid sinus pneumatisation and surrounding structures were investigated. Special attention was paid to the relationship between Onodi cell and the optic nerve canal, particularly in cases when the optic nerve canal was bulging by more than 50% into the Onodi cell (Type IV).</p><p><strong>Results: </strong>The Onodi cell was detected in 21.6% of cases, with the most common being Type I (48.5% right, 54.3% left). Type IV bulging of the optic nerve canal into the Onodi cell was observed in 47.1% of cases on the right side, 41.2% on the left side and bilateral in 11.7% of cases.</p><p><strong>Conclusions: </strong>In our series, we observed a high prevalence of Type IV optic nerve bulging into the Onodi cell. For this reason, we suggest that clinicians should always try to identify it in a pre-operative setting with computed tomography to avoid catastrophic consequences during endoscopic sinus surgery approaching the sphenoid area.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"36-41"},"PeriodicalIF":2.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of nasal vestibule carcinomas: recommendations by the Oncological Committee of the Italian Society of Otorhinolaryngology - Head and Neck Surgery. 鼻前庭癌的治疗:意大利耳鼻咽喉-头颈外科协会肿瘤委员会的建议。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 DOI: 10.14639/0392-100X-N2786
Francesco Bussu, Luca Tagliaferri, Michaele Francesco Corbisiero, Cecilia Lotto, Raul Pellini, Pierre Guarino, Giuseppe Mercante, Andrea Galuppi, Francesco Cariti, Giovanni Almadori, Francesco Longo, Luca Calabrese, Jacopo Galli, Livio Presutti, Piero Nicolai, Gabriele Molteni

Objective: Squamous cell carcinoma of the nasal vestibule (NV SCC) is a head and neck malignancy for which there is no established consensus on most aspects of clinical management. The purpose of this document is to give updated recommendations that incorporate recent evidence on its clinical characteristics and the high efficacy of brachytherapy as primary treatment modality.

Methods: A working group consisting of the members of the Scientific Committee for Oncology and Reconstructive Surgery of the Italian Society of Otorhinolaryngology Head and Neck Surgery and radiation oncologists expert in brachytherapy was formed to achieve a consensus.

Results: Consensus was reached on a set of recommendations, proposing a refined anatomical definition of the nasal vestibule, a novel T staging system of the NV SCC, and brachytherapy as standard of care, with a new method for catheter implantation.

Conclusions: The Committee emphasises the critical role of an accurate classification in clinical practice and encourages further research to validate the novel staging system and further improve treatment strategies. Where appropriate, it is recommended that patients be referred to centres with specific experience in brachytherapy for NV SCC.

目的:鼻前庭鳞状细胞癌(NV SCC)是一种头颈部恶性肿瘤:鼻前庭鳞状细胞癌(NV SCC)是一种头颈部恶性肿瘤,其临床治疗的大多数方面尚未达成共识。本文件旨在提供最新建议,纳入有关其临床特征的最新证据以及近距离放射治疗作为主要治疗方式的高效性:方法:为达成共识,成立了一个由意大利耳鼻咽喉头颈外科协会肿瘤与整形外科科学委员会成员和近距离放射治疗专家组成的工作组:结果:委员会就一系列建议达成共识,提出了鼻前庭的精细解剖学定义、新颖的NV SCC T分期系统、近距离放射治疗标准以及导管植入的新方法:委员会强调准确分类在临床实践中的关键作用,并鼓励开展进一步研究,以验证新型分期系统并进一步改进治疗策略。在适当的情况下,委员会建议将患者转诊至在近距离放射治疗 NV SCC 方面具有特殊经验的中心。
{"title":"Management of nasal vestibule carcinomas: recommendations by the Oncological Committee of the Italian Society of Otorhinolaryngology - Head and Neck Surgery.","authors":"Francesco Bussu, Luca Tagliaferri, Michaele Francesco Corbisiero, Cecilia Lotto, Raul Pellini, Pierre Guarino, Giuseppe Mercante, Andrea Galuppi, Francesco Cariti, Giovanni Almadori, Francesco Longo, Luca Calabrese, Jacopo Galli, Livio Presutti, Piero Nicolai, Gabriele Molteni","doi":"10.14639/0392-100X-N2786","DOIUrl":"10.14639/0392-100X-N2786","url":null,"abstract":"<p><strong>Objective: </strong>Squamous cell carcinoma of the nasal vestibule (NV SCC) is a head and neck malignancy for which there is no established consensus on most aspects of clinical management. The purpose of this document is to give updated recommendations that incorporate recent evidence on its clinical characteristics and the high efficacy of brachytherapy as primary treatment modality.</p><p><strong>Methods: </strong>A working group consisting of the members of the Scientific Committee for Oncology and Reconstructive Surgery of the Italian Society of Otorhinolaryngology Head and Neck Surgery and radiation oncologists expert in brachytherapy was formed to achieve a consensus.</p><p><strong>Results: </strong>Consensus was reached on a set of recommendations, proposing a refined anatomical definition of the nasal vestibule, a novel T staging system of the NV SCC, and brachytherapy as standard of care, with a new method for catheter implantation.</p><p><strong>Conclusions: </strong>The Committee emphasises the critical role of an accurate classification in clinical practice and encourages further research to validate the novel staging system and further improve treatment strategies. Where appropriate, it is recommended that patients be referred to centres with specific experience in brachytherapy for NV SCC.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"44 1","pages":"13-20"},"PeriodicalIF":2.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laryngopharyngeal reflux and idiopathic vocal fold scars. 咽喉反流和特发性声带瘢痕。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 Epub Date: 2023-12-29 DOI: 10.14639/0392-100X-N2625
Giovanna Cantarella, Jerome R Lechien, Lorenzo Pignataro, Mirko Aldè, Ludovica Battilocchi, Maria Rosaria Barillari
{"title":"Laryngopharyngeal reflux and idiopathic vocal fold scars.","authors":"Giovanna Cantarella, Jerome R Lechien, Lorenzo Pignataro, Mirko Aldè, Ludovica Battilocchi, Maria Rosaria Barillari","doi":"10.14639/0392-100X-N2625","DOIUrl":"10.14639/0392-100X-N2625","url":null,"abstract":"","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"68-70"},"PeriodicalIF":2.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity and reliability of the Questionnaire of Olfactory Disorders for Italian-speaking patients with olfactory dysfunction. 针对讲意大利语的嗅觉功能障碍患者的嗅觉障碍问卷的有效性和可靠性。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-02-01 DOI: 10.14639/0392-100X-N2736
Luigi Angelo Vaira, Giancarlo Tirelli, Davide Rizzo, Francesco Uderzo, Francesco Avanzini, Franco Trabalzini, Nicoletta Rivelli, Doris Burger, Luca Calabrese, Paolo Solla, Francesco Bussu, Miguel Mayo-Yáñez, Jerome R Lechien, Giacomo De Riu, Paolo Boscolo-Rizzo

Objective: To translate and validate an Italian version of the Questionnaire of Olfactory Disorders (IT-QOD).

Materials and methods: This is a prospective, multicentre study that involved patients with olfactory dysfunction (OD). Both cases and controls underwent administration of the IT-QOD, Sino-Nasal Outcome Test-22 (SNOT-22) and psychophysical evaluation of orthonasal and retronasal olfactory function.

Results: The IT-QOD was administered to 96 patients and 38 controls. The Cronbach's alpha exceeded 0.90, indicating satisfactory internal consistency. The test-retest reliability was found to be high for both parosmia (rs = 0.944) and life quality (rs = 0.969). Patients with OD had significantly higher IT-QOD scores compared to healthy individuals (p < 0.001), indicating strong internal validity. The external validity was also satisfactory, as shown by the significant correlation with SNOT-22 (rs = -0.54) and the threshold, discrimination, and identification score (rs = -0.63).

Conclusions: The IT-QOD was demonstrated to be reliable and valid to assess the impact of OD on the quality of life of Italian-speaking patients.

目的:翻译并验证意大利语版的嗅觉障碍问卷(IT-QOD):翻译并验证意大利语版的嗅觉障碍问卷(IT-QOD):这是一项涉及嗅觉功能障碍(OD)患者的前瞻性多中心研究。病例和对照组均接受了 IT-QOD、Sino-Nasal Outcome Test-22 (SNOT-22) 测试,并对正鼻腔和反鼻腔嗅觉功能进行了心理物理评估:结果:96 名患者和 38 名对照者接受了 IT-QOD 测试。Cronbach'sα超过0.90,表明内部一致性令人满意。结果发现,副嗅觉(rs = 0.944)和生活质量(rs = 0.969)的测试-再测可靠性都很高。与健康人相比,OD 患者的 IT-QOD 得分明显更高(p < 0.001),这表明内部效度很高。IT-QOD与SNOT-22(rs = -0.54)以及阈值、辨别力和识别力评分(rs = -0.63)之间的显著相关性也表明其外部效度令人满意:IT-QOD在评估OD对意大利语患者生活质量的影响方面被证明是可靠有效的。
{"title":"Validity and reliability of the Questionnaire of Olfactory Disorders for Italian-speaking patients with olfactory dysfunction.","authors":"Luigi Angelo Vaira, Giancarlo Tirelli, Davide Rizzo, Francesco Uderzo, Francesco Avanzini, Franco Trabalzini, Nicoletta Rivelli, Doris Burger, Luca Calabrese, Paolo Solla, Francesco Bussu, Miguel Mayo-Yáñez, Jerome R Lechien, Giacomo De Riu, Paolo Boscolo-Rizzo","doi":"10.14639/0392-100X-N2736","DOIUrl":"10.14639/0392-100X-N2736","url":null,"abstract":"<p><strong>Objective: </strong>To translate and validate an Italian version of the Questionnaire of Olfactory Disorders (IT-QOD).</p><p><strong>Materials and methods: </strong>This is a prospective, multicentre study that involved patients with olfactory dysfunction (OD). Both cases and controls underwent administration of the IT-QOD, Sino-Nasal Outcome Test-22 (SNOT-22) and psychophysical evaluation of orthonasal and retronasal olfactory function.</p><p><strong>Results: </strong>The IT-QOD was administered to 96 patients and 38 controls. The Cronbach's alpha exceeded 0.90, indicating satisfactory internal consistency. The test-retest reliability was found to be high for both parosmia (rs = 0.944) and life quality (rs = 0.969). Patients with OD had significantly higher IT-QOD scores compared to healthy individuals (p < 0.001), indicating strong internal validity. The external validity was also satisfactory, as shown by the significant correlation with SNOT-22 (rs = -0.54) and the threshold, discrimination, and identification score (rs = -0.63).</p><p><strong>Conclusions: </strong>The IT-QOD was demonstrated to be reliable and valid to assess the impact of OD on the quality of life of Italian-speaking patients.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"44 1","pages":"42-51"},"PeriodicalIF":2.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indirect laryngeal surgery of vocal fold polyps: a dying or evolving art? 声带息肉的喉间接手术:濒临消亡还是不断发展的艺术?
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-12-01 Epub Date: 2023-07-28 DOI: 10.14639/0392-100X-N2487
Ognjen Cukic, Dejan Radaljac, Nenad Arsovic, Milan Jovanovic, Zoran Milutinovic

Objective: Vocal fold polyps (VFPs) are the most common benign laryngeal lesions that require surgery and are routinely managed by microlaryngoscopy (MLS) under general anaesthesia. Prior to introduction of MLS, VFPs were removed using indirect laryngoscopic surgery (ILS) in local anaesthesia, a procedure that required substantial surgical skill to operate with an unmagnified mirror view of the larynx. With the adoption of wireless endoscopy equipment and personal computers, we tried to simplify this technique so that it can be easily performed in the office. This study aimed to assess the effectiveness of ILS by comparing voice outcomes with MLS.

Materials and methods: ILS and MLS were performed in six patients each. Treatment outcomes were measured using a voice self-assessment and objective acoustic analysis. The total cost of both procedures was calculated.

Results: Both techniques allowed successful removal of VFPs in all patients, without significant intergroup differences in voice outcomes. The cost of ILS was significantly lower.

Conclusions: Despite the pilot nature of the study and the small sample size, our data indicate the potential value of this technique which, considering its simplicity and economic value could be used as an alternative to MLS in carefully selected patients.

目的:声带息肉(VFPs)是最常见的喉部良性病变,需要进行手术治疗,常规治疗方法是在全身麻醉的情况下进行显微喉镜手术(MLS)。在引入显微喉镜之前,VFP 是在局部麻醉的情况下通过间接喉镜手术(ILS)切除的,这种手术需要高超的手术技巧,才能在没有放大镜的情况下对喉部进行操作。随着无线内窥镜设备和个人电脑的采用,我们尝试简化这项技术,使其能够在诊室中轻松完成。本研究旨在通过比较 ILS 和 MLS 的嗓音效果来评估 ILS 的有效性:ILS 和 MLS 各对六名患者进行了治疗。治疗结果通过嗓音自我评估和客观声学分析进行测量。计算了两种手术的总费用:结果:两种技术都能成功去除所有患者的 VFP,且嗓音效果无明显组间差异。ILS的费用明显更低:尽管该研究属于试验性质,且样本量较小,但我们的数据表明了该技术的潜在价值,考虑到其简便性和经济价值,该技术可用于精心挑选的患者,作为 MLS 的替代方法。
{"title":"Indirect laryngeal surgery of vocal fold polyps: a dying or evolving art?","authors":"Ognjen Cukic, Dejan Radaljac, Nenad Arsovic, Milan Jovanovic, Zoran Milutinovic","doi":"10.14639/0392-100X-N2487","DOIUrl":"10.14639/0392-100X-N2487","url":null,"abstract":"<p><strong>Objective: </strong>Vocal fold polyps (VFPs) are the most common benign laryngeal lesions that require surgery and are routinely managed by microlaryngoscopy (MLS) under general anaesthesia. Prior to introduction of MLS, VFPs were removed using indirect laryngoscopic surgery (ILS) in local anaesthesia, a procedure that required substantial surgical skill to operate with an unmagnified mirror view of the larynx. With the adoption of wireless endoscopy equipment and personal computers, we tried to simplify this technique so that it can be easily performed in the office. This study aimed to assess the effectiveness of ILS by comparing voice outcomes with MLS.</p><p><strong>Materials and methods: </strong>ILS and MLS were performed in six patients each. Treatment outcomes were measured using a voice self-assessment and objective acoustic analysis. The total cost of both procedures was calculated.</p><p><strong>Results: </strong>Both techniques allowed successful removal of VFPs in all patients, without significant intergroup differences in voice outcomes. The cost of ILS was significantly lower.</p><p><strong>Conclusions: </strong>Despite the pilot nature of the study and the small sample size, our data indicate the potential value of this technique which, considering its simplicity and economic value could be used as an alternative to MLS in carefully selected patients.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"424-429"},"PeriodicalIF":2.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10274169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment and outcomes of minor salivary gland cancers of the larynx and trachea: a systematic review. 喉和气管小涎腺癌的治疗和结果:一项系统综述。
IF 2.1 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-12-01 Epub Date: 2023-10-10 DOI: 10.14639/0392-100X-N2635
Claudia Montenegro, Davide Mattavelli, Davide Lancini, Alberto Paderno, Elisa Marazzi, Vittorio Rampinelli, Michele Tomasoni, Cesare Piazza

Objectives: Malignant minor salivary glands carcinomas (MiSGC) of the larynx and trachea are rare tumours and published evidence is sparse. We conducted a systematic review to describe shareable treatment strategies and oncological outcomes of these neoplastic entities.

Methods: Full text English manuscripts published from January 1st 2000 to December 14th 2022 were included. Data on demographics, treatments and outcomes were collected. A pooled analysis of 5-year overall survival (OS) was performed.

Results: Seventeen articles and 365 patients met the inclusion criteria. The most common subsites involved were subglottic and distal trachea. Adenoid cystic carcinoma was, by far, the most frequent histotype. The first-choice treatment strategy was surgery (86.8%), while adjuvant treatments were delivered in 57.4% of patients. Only 12.9% were treated with definitive radiotherapy with/without chemotherapy. The mean follow-up was 68.3 months. One hundred nine (34.9%) deaths were recorded and 62.4% were cancer-related. Five-year OS ranged from 20% to 100% and, at pooled analysis, it was 83% (range, 78-87%).

Conclusions: In case of MiSGC of the larynx and trachea, surgery remains the mainstay of treatment. Adjuvant treatments are frequently delivered. Survival estimates are good overall, but highly heterogeneous.

目的:喉和气管的恶性小唾液腺癌(MiSGC)是罕见的肿瘤,已发表的证据很少。我们进行了一项系统综述,以描述这些肿瘤实体的可共享治疗策略和肿瘤学结果。方法:收录2000年1月1日至2022年12月14日出版的英文全文手稿。收集有关人口统计、治疗和结果的数据。对5年总生存期(OS)进行了汇总分析。结果:17篇文章和365名患者符合纳入标准。最常见的病变是声门下和气管远端。腺样囊性癌是迄今为止最常见的组织类型。首选的治疗策略是手术(86.8%),而57.4%的患者接受了辅助治疗。只有12.9%的患者接受了明确的放疗加/不加化疗。平均随访68.3个月。记录了109例(34.9%)死亡,62.4%与癌症相关。五年OS的范围为20%至100%,综合分析为83%(范围为78%-87%)。结论:对于喉和气管的MiSGC,手术仍然是治疗的主要手段。经常提供辅助治疗。总体而言,生存率的估计是好的,但高度异质性。
{"title":"Treatment and outcomes of minor salivary gland cancers of the larynx and trachea: a systematic review.","authors":"Claudia Montenegro, Davide Mattavelli, Davide Lancini, Alberto Paderno, Elisa Marazzi, Vittorio Rampinelli, Michele Tomasoni, Cesare Piazza","doi":"10.14639/0392-100X-N2635","DOIUrl":"10.14639/0392-100X-N2635","url":null,"abstract":"<p><strong>Objectives: </strong>Malignant minor salivary glands carcinomas (MiSGC) of the larynx and trachea are rare tumours and published evidence is sparse. We conducted a systematic review to describe shareable treatment strategies and oncological outcomes of these neoplastic entities.</p><p><strong>Methods: </strong>Full text English manuscripts published from January 1<sup>st</sup> 2000 to December 14<sup>th</sup> 2022 were included. Data on demographics, treatments and outcomes were collected. A pooled analysis of 5-year overall survival (OS) was performed.</p><p><strong>Results: </strong>Seventeen articles and 365 patients met the inclusion criteria. The most common subsites involved were subglottic and distal trachea. Adenoid cystic carcinoma was, by far, the most frequent histotype. The first-choice treatment strategy was surgery (86.8%), while adjuvant treatments were delivered in 57.4% of patients. Only 12.9% were treated with definitive radiotherapy with/without chemotherapy. The mean follow-up was 68.3 months. One hundred nine (34.9%) deaths were recorded and 62.4% were cancer-related. Five-year OS ranged from 20% to 100% and, at pooled analysis, it was 83% (range, 78-87%).</p><p><strong>Conclusions: </strong>In case of MiSGC of the larynx and trachea, surgery remains the mainstay of treatment. Adjuvant treatments are frequently delivered. Survival estimates are good overall, but highly heterogeneous.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"365-374"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of middle ear function after conventional or endoscopic microdebrider assisted adenoidectomy. 常规或内窥镜微型ebrider辅助腺样体切除术后中耳功能评估。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-12-01 Epub Date: 2023-10-10 DOI: 10.14639/0392-100X-N2593
Oj Giri, S Vijendra Shenoy, Navya Parvathareddy, Praneetha Puvvula, Deeksha Shetty, Nayanika Reddy

Objectives: To compare pre- and post-operative pure tone audiometric and impedance audiometric analysis following conventional and endoscopic microdebrider assisted adenoidectomy and compare the outcomes.

Methods: Patients diagnosed with chronic adenoiditis were divided in groups of 25 each. Patients in the first group underwent conventional curettage adenoidectomy, while those in second group underwent endoscopic microdebrider assisted adenoidectomy. Pre- and post-operative pure tone and impedance audiometry were performed for all patients and outcomes were compared.

Results: The endoscopic microdebrider assisted method resulted in significantly better outcomes compared to conventional curettage. Criteria such as hearing threshold (p value 0.004 at second follow-up), peak pressure (p value 0.045 at first follow-up) and tympanogram (p value 0.016) showed that the endoscopic method was better, while peak compliance (p value 0.340 at first follow-up) did not show any significant difference between groups.

Conclusions: The endoscopic microdebrider assisted method for adenoidectomy has a definite advantage of better visualisation resulting in better clearance of tissue, leading to enhanced middle ear function compared to conventional curettage.

目的:比较常规和内窥镜微创辅助腺样体切除术前后纯音听力和阻抗听力分析,并比较结果。方法:将诊断为慢性腺样体炎的患者分为25组。第一组患者接受了传统的刮除腺样体切除术,而第二组患者则接受了内窥镜微创辅助腺样体摘除术。对所有患者进行术前和术后纯音和阻抗测听,并比较结果。结果:与传统刮宫术相比,内窥镜微创刮宫术的效果明显更好。听力阈值(第二次随访时p值为0.004)、峰值压力(第一次随访时p值为0.045)和鼓室图(p值为0.016)等标准表明内镜方法更好,而峰值依从性(第一次跟进时p值0.340)在各组之间没有显着差异。结论:与传统刮宫术相比,内窥镜微型ebrider辅助腺样体切除术具有更好的可视化效果,可以更好地清除组织,从而增强中耳功能。
{"title":"Assessment of middle ear function after conventional or endoscopic microdebrider assisted adenoidectomy.","authors":"Oj Giri, S Vijendra Shenoy, Navya Parvathareddy, Praneetha Puvvula, Deeksha Shetty, Nayanika Reddy","doi":"10.14639/0392-100X-N2593","DOIUrl":"10.14639/0392-100X-N2593","url":null,"abstract":"<p><strong>Objectives: </strong>To compare pre- and post-operative pure tone audiometric and impedance audiometric analysis following conventional and endoscopic microdebrider assisted adenoidectomy and compare the outcomes.</p><p><strong>Methods: </strong>Patients diagnosed with chronic adenoiditis were divided in groups of 25 each. Patients in the first group underwent conventional curettage adenoidectomy, while those in second group underwent endoscopic microdebrider assisted adenoidectomy. Pre- and post-operative pure tone and impedance audiometry were performed for all patients and outcomes were compared.</p><p><strong>Results: </strong>The endoscopic microdebrider assisted method resulted in significantly better outcomes compared to conventional curettage. Criteria such as hearing threshold (p value 0.004 at second follow-up), peak pressure (p value 0.045 at first follow-up) and tympanogram (p value 0.016) showed that the endoscopic method was better, while peak compliance (p value 0.340 at first follow-up) did not show any significant difference between groups.</p><p><strong>Conclusions: </strong>The endoscopic microdebrider assisted method for adenoidectomy has a definite advantage of better visualisation resulting in better clearance of tissue, leading to enhanced middle ear function compared to conventional curettage.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"417-423"},"PeriodicalIF":2.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normative data for interpreting the SNOT-22. 解释SNOT-22的规范性数据。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-12-01 Epub Date: 2023-10-10 DOI: 10.14639/0392-100X-N2279
Michaela Plath, Matthias Sand, Carlo Cavaliere, Peter K Plinkert, Ingo Baumann, Karim Zaoui

Objectives: The Sino-Nasal Outcome Test 22 (SNOT-22) is a validated patient-reported outcome instrument to evaluate the health-related quality of life (HRQoL) in patients with chronic rhinosinusitis (CRS). There are no published normative SNOT-22 scores, limiting its interpretation.

Methods: Symptom scores from 1,000 SNOT-22 questionnaires were analysed by principal component analysis (PCA) and exploratory factor analyses. Data were derived from a survey with 1,000 healthy Europeans (reference cohort) who were recruited using the Respondi panel for market and social science research. This subsample was quoted to the population distribution of the German Microcensus and selected from a non-probability panel.

Results: The overall normative SNOT-22 score can be detected to be 20.2 ± 19.44. Male (18.49 ± 19.15) and older (> 50 years old; 18.3 ± 17.49) participants had overall lower SNOT-22 mean results than females (21.8 ± 19.6) and younger (21.4 ± 20.55) participants, indicating higher levels of satisfaction. PCA proposed two SNOT-22 domains ("physiological well-being" and "psychological well-being"), which explained 65% of the variance.

Conclusions: These are the first published (German) normative scores for the SNOT-22 and provide a clinical reference point for the interpretation of data.

目的:中国鼻结果测试22(SNOT-22)是一种经验证的患者报告结果工具,用于评估慢性鼻窦炎(CRS)患者的健康相关生活质量(HRQoL)。目前还没有公布标准SNOT-22评分,限制了其解释。方法:采用主成分分析(PCA)和探索性因素分析(EFA)对1000份SNOT-22问卷的症状评分进行分析。数据来源于对1000名健康欧洲人(参考队列)的调查,这些人是使用Respondi市场和社会科学研究小组招募的。这一子样本被引用到德国微型企业的人口分布中,并从非概率小组中选出。结果:SNOT-22总分为20.2±19.44。男性(18.49±19.15)和年龄较大(>50岁;18.3±17.49)的参与者的SNOT-22平均结果总体上低于女性(21.8±19.6)和年龄较小(21.4±20.55)的参与者,表明满意度较高。PCA提出了两个SNOT-22域(“生理幸福感”和“心理幸福感”),解释了65%的方差。结论:这些是首次公布的(德国)SNOT-22的规范性评分,为数据解释提供了临床参考点。
{"title":"Normative data for interpreting the SNOT-22.","authors":"Michaela Plath, Matthias Sand, Carlo Cavaliere, Peter K Plinkert, Ingo Baumann, Karim Zaoui","doi":"10.14639/0392-100X-N2279","DOIUrl":"10.14639/0392-100X-N2279","url":null,"abstract":"<p><strong>Objectives: </strong>The Sino-Nasal Outcome Test 22 (SNOT-22) is a validated patient-reported outcome instrument to evaluate the health-related quality of life (HRQoL) in patients with chronic rhinosinusitis (CRS). There are no published normative SNOT-22 scores, limiting its interpretation.</p><p><strong>Methods: </strong>Symptom scores from 1,000 SNOT-22 questionnaires were analysed by principal component analysis (PCA) and exploratory factor analyses. Data were derived from a survey with 1,000 healthy Europeans (reference cohort) who were recruited using the Respondi panel for market and social science research. This subsample was quoted to the population distribution of the German Microcensus and selected from a non-probability panel.</p><p><strong>Results: </strong>The overall normative SNOT-22 score can be detected to be 20.2 ± 19.44. Male (18.49 ± 19.15) and older (> 50 years old; 18.3 ± 17.49) participants had overall lower SNOT-22 mean results than females (21.8 ± 19.6) and younger (21.4 ± 20.55) participants, indicating higher levels of satisfaction. PCA proposed two SNOT-22 domains (\"physiological well-being\" and \"psychological well-being\"), which explained 65% of the variance.</p><p><strong>Conclusions: </strong>These are the first published (German) normative scores for the SNOT-22 and provide a clinical reference point for the interpretation of data.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":" ","pages":"390-399"},"PeriodicalIF":2.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Otorhinolaryngologica Italica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1